Gorlova, Olga Y.
Gorlov, Ivan P.
Ripley, R. Taylor
Cheng, Chao
Li, Yafang
Peng, Bo
Liu, Yanhong
Jang, Hee-Jin
Kang, Sung Wook
Lee, Claire
Ranchod, Priyanka
Burt, Bryan M.
Lee, Hyun-Sung
Amos, Christopher I.
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-23-IAHU-007)
Cancer Prevention Research Institute of Texas (RR170048, RR170048, RR170048)
National Institutes of Health (R03CA282953, U24 2U24OH009077-15-00, R01CA243483, R21AI159379, U24 2U24OH009077-15-00, R37 (R01) CA289419-01, U19CA203654, U19CA203654)
US Department of Defense (W81XWH-22-1-0657, W81XWH-22-1-0657)
Article History
Received: 4 December 2024
Accepted: 30 July 2025
First Online: 22 August 2025
Declarations
:
: This study was approved by Institutional Review Board protocol at Baylor College of Medicine (H-35782) and performed in accordance with Institutional Review Board protocol at Baylor College of Medicine (H-35782). Informed consent was obtained from all study participants for the collection of clinical data and biospecimens.
: The authors declare no competing interests.